You are now viewing our public site. Back to Dashboard

Drug Treatment for Coronary Artery Disease

presented by Barbara Gladson

Accrediting Body:

Target Audience:

Levels:
Disclosure Statement:

Financial: Barbara Gladson receives compensation from MedBridge for this course. There is no financial interest beyond the production of this course.


 Non-Financial: Barbara Gladson has no competing non-financial interests or relationships with regard to the content presented in this course.

Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.

MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact support@medbridgeed.com. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.

Accreditation Check:
This course summarizes the pathophysiology of cardiac disease with regard to its pharmacologic treatment. Students will learn about nitroglycerin and how to use the patient’s response to differentiate angina from an MI. Students will also learn about drugs for high cholesterol and how to distinguish their side effects from true musculoskeletal impairments. The course will also cover drug treatment for congestive heart failure and explain the limitations of antiarrhythmic drugs.

Meet Your Instructor

Barbara Gladson, PT, OT, PhD

Dr. Gladson has earned a BS from the University of Pennsylvania in Occupational Therapy, a MS degree in Physical Therapy from Columbia and a PhD in Pharmacology from the Rutgers Graduate School of Biomedical Sciences. She is the Associate Dean for Academic Affairs in the School of Health Professions, and the Director of the Rutgers…

Read full bio

Chapters & Learning Objectives

1. Angina

In chapter one, Barbara Gladson will define Angina, Mechanism of action of Nitroglycerin, and the administration of sublingual Nitro to reduce Angina.

2. Clot Prevention and Treatment

Chapter two will discuss the role of platelet aggregator inhibitors, anticoagulants, and thrombolytics in coronary heart disease and their implications for therapeutic interventions. Barbara Gladson will cover the controversial role of aspirin in preventing cardiac events and explain the dosing regimen for a patient who takes NSAIDs for arthritis and low-dose aspirin for cardio protection.

3. Lipid Control

Barbara Gladson will explain the role of statins in reducing high cholesterol and assess patient response to determine statin related problems in this chapter. She will also list agents used to improve organ perfusion in Congestive Heart Disease and

4. Heart Failure

In the final lecture chapter, Gladson will review heart failure and the stages of therapy. She will also cover cognitive function in association with heart failure and other conditions connected to it.

5. Question and Answer

A question and answer session with Barbara Gladson and PT Holly Tanner, in which they will discuss the topics cover in this course and how they relate to practice.

Sign up to receive exclusive content from industry leading instructors.

Send us feedback

Email